The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
CD86 molecule is the ligand for both costimulatory (CD28) and coinhibitory (CTLA-4) molecules, and it regulates immune response after allogeneic hematopoietic stem cell transplantation (alloHSCT). Therefore, we postulate that CD86 gene variations might influence the outcome after alloHSCT. Altogethe...
Saved in:
Main Authors: | Lidia Karabon, Miroslaw Markiewicz, Karolina Chrobot, Monika Dzierzak-Mietla, Edyta Pawlak-Adamska, Anna Partyka, Anna Koclega, Slawomira Kyrcz-Krzemien, Irena Frydecka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/3826989 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Patrycja Zielinska, et al.
Published: (2014-01-01) -
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01) -
Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
by: Silje Johansen, et al.
Published: (2022-01-01) -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01) -
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
by: Mary Nauffal, et al.
Published: (2024-01-01)